Pay in installments of $5.25 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
BD Vacutainer Glass Citrate Tube with Light Blue Hemogard x 100367691 13 x 75 mm x 4. 5 mL BD Vacutainer Light blue BD Hemogard closure. Block label. CE. Additive: 0. 105 molar buffered sodium citrate solution and siliconized interior (100 sp, 1000 cs)
367691 - 13 x 75 mm x 4.5 mL BD Vacutainer ® Light blue BD Hemogardâ„¢ closure. Block label. CE. Additive: 0.105 molar buffered sodium citrate solution and siliconized interior (100/sp, 1000/cs)
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.3 ★★★★★
Based on 12 reviews
Sort
Product Reviews
★★★★★ 5
Good stuff
Perfect for 2 amplifiers. Pretty affordable. Good material. Straight forward installation.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 24, 2026
★★★★★ 4
Good price
Good quality for the price
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 18, 2025
★★★★★ 5
Good bang for your buck
Realy nice
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 30, 2026
★★★★★ 5
Perfect
Exactly what I needed to split power between amps.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 19, 2026
★★★★★ 5
Cood product, no issues as yet.
Works, easy to put in-line, as they shouldn't be seen looks don't matter.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 9, 2025